Arbutus Reports Fourth Quarter and Year-end 2018 Financial Results and Describes Recent Clinical Accomplishments and Key 2019 Objectives

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. CBRS
2. FDX
3. KBH
4. HON
5. HTZ
6. MRK
7. TTWO
8. USO
9. QCOM
10. INFY

Go back to Arbutus Reports Fourth Quarter and Year-end 2018 Financial Results and Describes Recent Clinical Accomplishments and Key 2019 Objectives

Arbutus Biopharma (ABUS) Reports FY18 Loss of $1.21

March 7, 2019 4:10 PM EST

Arbutus Biopharma (NASDAQ: ABUS) reported FY18 EPS of ($1.21), versus ($1.56) reported last year. Revenue for the year came in at $5.9 million, versus $10.7 million reported last year.

For earnings history and earnings-related data on Arbutus Biopharma (ABUS) click here.

... More